Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDEliem Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q2 2024 | 1 | $1.54 | $1.54 | $1.54 |
Eliem Therapeutics, Inc. Earnings Date And Information
Eliem Therapeutics, Inc. last posted its earnings results on Thursday, May 11th, 2023. The company reported $-0.84 earnings per share for the quarter, missing analysts' consensus estimates of $-0.28 by $0.56. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Eliem Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.3 diluted earnings per share) and currently has a price-to-earnings ratio of 0. Eliem Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
Eliem Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/14/2024 | Q2 2024 | -$1.81 | $0 | $0 | ||
| 05/15/2024 | Q1 2024 | -$0.06 | $0 | |||
| 04/29/2024 | Q4 2023 | -$0.13 | $0 | |||
| 11/14/2023 | Q3 2023 | -$0.15 | $0 | |||
| 08/10/2023 | Q2 2023 | -$0.19 | $0 | |||
| 05/11/2023 | Q1 2023 | -$0.28 | -$0.80 | -0.52 | $0 | |
| 03/06/2023 | Q4 2022 | -$0.44 | -$0.23 | 0.21 | $0 | |
| 11/14/2022 | Q3 2022 | -$0.42 | -$0.37 | 0.05 | $0 | |
| 08/15/2022 | Q2 2022 | -$0.47 | -$0.59 | -0.12 | $0 | |
| 05/16/2022 | Q1 2022 | -$0.57 | -$0.51 | 0.06 | $0 | |
| 03/07/2022 | Q4 2021 | -$0.70 | -$0.40 | 0.3 | $0 | |
| 11/08/2021 | Q3 2021 | -$1.17 | -$0.62 | 0.55 | $0 | |
| 09/13/2021 | Q2 2021 | -$1.86 | -$0.37 | 1.49 | $0 | |
| 03/30/2021 | Q1 2021 | -$1.60 | $0 | |||
| 12/30/2020 | Q4 2020 | -$1.27 | $0 | |||
| 09/29/2020 | Q3 2020 | -$0.19 | $0 | |||
| 06/29/2020 | Q2 2020 | -$0.14 | $0 | |||
| 03/30/2020 | Q1 2020 | -$0.16 | $0 |
Eliem Therapeutics, Inc. Earnings: FAQ's
When is Eliem Therapeutics, Inc.'s earnings date?
Eliem Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
How can I listen to Eliem Therapeutics, Inc.'s earnings conference
call?
The conference call for Eliem Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Eliem Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Eliem Therapeutics, Inc.'s latest earnings report can be read online.
How much profit does Eliem Therapeutics, Inc. generate each year?
Eliem Therapeutics, Inc. (:ELYM) has a recorded net income of $0. Eliem Therapeutics, Inc. has generated $-1.3 earnings per share over the last four quarters.